The gene editing company, backed by investors including Pfizer, is set to raise almost double its initial target, after pricing a flotation of 5.5 million shares.

Imperial Innovations launches incubator focused on science and technology.

Manchester wastewater treatment spin-out Arvia closes investment from Parkwalk for undisclosed sum.

State-backed Wave Energy Scotland launches international technology innovation competition.

The robotic arm developer has raised series A funding in a round backed by Abacus Alpha and High-Tech Gruenderfonds.

Antibody developer XO1, backed by a Johnson & Johnson-backed fund, has been acquired by another Johnson & Johnson subsidiary, Janssen Parmaceuticals.